SAB Biotherapeutics ($SABS) Insider Trading & Smart Money Activity
SAB Biotherapeutics, Inc. ($SABS) has 1 insider trade and 6 analyst ratings on file. Insiders filed 1 Form 4 transaction in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 6
SABS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All SABS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Alexandra KropotovaCHIEF MEDICAL OFFICER | Sell (Tax withholding) | 988 sh | +1.3% | -11.1% | — | |||||
| Analyst | Barclays | Reiterates to buy | PT $13 | +1.0% | -8.6% | Read | |||||
| Analyst | Chardan Capital | Reiterates to buy | PT $16 | -0.5% | -8.3% | Read | |||||
| Analyst | Leerink Partners | Reiterates to buy | PT $12 | +0.8% | -7.2% | Read | |||||
| Analyst | Leerink Partners | Reiterates to buy | PT $12 | +0.8% | -7.2% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $10 | +0.8% | -7.2% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $10 | +0.8% | -7.2% | Read |
1W / 1M / 6M = how SABS moved from the trade or filing date.
Insider trading in SABS: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Alexandra Kropotova | CHIEF MEDICAL OFFICER | 1 | — | Jun 25, 2026 |
Analyst ratings on SABS
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Barclays | Reiterates | buy | $13 | +1.0% | -8.6% | Read | ||
| Chardan Capital | Reiterates | buy | $16 | -0.5% | -8.3% | Read | ||
| Leerink Partners | Reiterates | buy | $12 | +0.8% | -7.2% | Read | ||
| Leerink Partners | Reiterates | buy | $12 | +0.8% | -7.2% | Read | ||
| HC Wainwright | Reiterates | buy | $10 | +0.8% | -7.2% | Read | ||
| HC Wainwright | Reiterates | buy | $10 | +0.8% | -7.2% | Read |
Frequently asked questions
What is the latest insider trade in SABS?
Alexandra Kropotova, CHIEF MEDICAL OFFICER filed a sell (tax withholding) of 988 sh on Jun 25, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.